PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Center for HTA, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161, Rome, Italy. matteo.ruggeri@iss.it.\', \'School of Medicine, St. Camillus International University of Health Sciences (UniCamillus), Via di Sant\'Alessandro, 8, 00131, Rome, Italy. matteo.ruggeri@iss.it.\', \'Department of Business Administration, John Cabot University, Rome, Italy.\', \'School of Medicine, St. Camillus International University of Health Sciences (UniCamillus), Via di Sant\'Alessandro, 8, 00131, Rome, Italy.\', \'Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.\', \'Centro Hospitalar de Setúbal, Setúbal, Portugal.\', \'Centro Hospitalar Lisboa Norte, Hospital Santa Maria, Lisbon, Portugal.\', \'Maple Health Group, New York, NY, USA.\', \'NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40261-022-01128-8
?:doi
?:hasPublicationType
?:journal
  • Clinical drug investigation
is ?:pmid of
?:pmid
?:pmid
  • 35298832
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.719
?:rankingScore_hIndex
  • 49
?:title
  • Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all